Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 91Leukemia, Myeloid, Acute 77Precursor Cell Lymphoblastic Leukemia-Lymphoma 63Leukemia 49Lymphoma, Non-Hodgkin 45Lymphoma 41Leukemia, Lymphocytic, Chronic, B-Cell 41Hodgkin Disease 39Myeloproliferative Disorders 32Multiple Myeloma 30Leukemia, Myelogenous, Chronic, BCR-ABL Positive 30Leukemia, Myelomonocytic, Chronic 23Leukemia, Myeloid, Accelerated Phase 23Leukemia, Myeloid, Chronic-Phase 22Burkitt Lymphoma 22Lymphoma, Mantle-Cell 21Lymphoma, B-Cell, Marginal Zone 21Congenital Abnormalities 21Lymphoma, Follicular 20Primary Myelofibrosis 19Lymphoma, Large B-Cell, Diffuse 19Neoplasms, Plasma Cell 18Lymphoma, Large-Cell, Immunoblastic 18Graft vs Host Disease 18Myelodysplastic-Myeloproliferative Diseases 17Blast Crisis 17Anemia, Refractory, with Excess of Blasts 17Dendritic Cell Sarcoma, Interdigitating 15Leukemia, Myelomonocytic, Juvenile 14Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 14

Interventions

fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Melphalan 1Cyclophosphamide 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metabolism, Inborn Errors × Melphalan × Myeloid × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡